入院时的全血细胞计 (CBC) 衍生指数和ICU患者的短期结果:一项回顾性研究
Ravi Shukla1, Vinutha Silvanus2, Sagar Dahal3
1Department of Internal Medicine, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal.
Annals of medicine
|June 24, 2025
概括
中性粒细胞与淋巴细胞的比率 (NLR) 显示了一些预测值在ICU死亡率. 需要进一步的研究,以了解全血细胞计 (CBC) 衍生指数在预测患者结果中的作用.
科学领域:
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
- 生物统计学 生物统计学
背景情况:
- 完整血清 (CBC) 参数提供了对血液细胞成分的洞察力,并受到生理和病理压力的影响.
- 临床医生建议CBC衍生的指数可以预测炎症状况的结果.
- 调查这些指数与ICU患者短期结果的相关性至关重要.
研究的目的:
- 调查CBC衍生的指数与在重症监护室 (ICU) 住院患者的短期结果的相关性.
- 评估这些指数对死亡率,ICU住院和住院的预测价值.
主要方法:
- 对486名ICU患者进行了回顾性分析研究.
- 数据从ICU注册表和电子数据库中收集,包括入院时的CBC报告.
- 使用CBC参数计算各种指数,然后分析与短期结果的关联.
主要成果:
- 这项研究包括486名患者 (56%是男性,平均年龄为52.95岁).
- 在ICU的死亡率为19.7%,预测因素包括老年,低血红蛋白和败血症.
- 中性粒细胞与淋巴细胞的比率 (NLR) 显示了一些预测能力在ICU死亡率 (AUC 0.55),而总淋巴细胞计数 (TLC) 并没有显著差异.
结论:
- 中性粒细胞与淋巴细胞的比率 (NLR) 显示了在ICU中因任何原因死亡率的预测价值.
- 需要对诊断特异性队列进行进一步的研究,以澄清CBC衍生的参数中的动态变化对患者结果的作用.
更多相关视频
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Acute Kidney Injury I: Introduction
83
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
83
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
353
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353
Acute Respiratory Failure-II
384
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
384
Acute Respiratory Failure-III
339
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
339


